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Abstract: A three-dimensional bioengineered heart muscle
(BEHM) construct model had been previously developed,
exhibiting contractile forces up to 800 mN. The interest of
this study was to determine gene expression levels of bio-
logic markers involved in calcium-handling between
BEHM, cell monolayer, and neonatal heart. Cardiac cells
were isolated from one litter of F344 rats and organized into
groups (n = 5): 4-, 7-, 10-day BEHM and cell monolayer;
BEHM was evaluated for cell viability and contractility.
Groups were then analyzed for mRNA expression of
calcium-handling proteins: myosin heavy chain (MHC) a
and b, Sarcoplasmic reticulum Ca++ ATPase (SERCA) 2,
phospholamban (PBL), and ryanodine receptor. BEHM
exhibited electrically stimulated active force (208  12 mN
day 4, 361  22 mN day 7, and 344  29 mN day 10) and no
decrease in cell number. Real-time polymerase chain reac-
tion (PCR) showed an increase in gene expression of all
calcium-handling proteins in BEHM at 7 and 10 days com-
pared with monolayers, for example, comparing BEHM to
monolayer (7 and 10 days, respectively), MHC-a: 2600-fold
increase and a 100-fold increase;MHC-b: 70-fold increase at
10 days; ryanodine receptor: 74-fold increase at 10 days;
SERCA: 19-fold increase and sixfold increase; PBL: 158-
fold increase and 24-fold increase. It was concluded
that a three-dimensional environment is a better culturing
condition of cardiac cells than a monolayer. Also, BEHM
constructs demonstrated a high similarity to a native myo-
cardium, and is, thus, a good starting foundation for engi-
neered heart muscle. Key Words: Real-time polymerase
chain reaction—Tissue engineering—Cardiac myocytes—
Fibrinogen/fibrin—Active force—Myosin heavy chain
—Sarcoplasmic reticulum Ca++ ATPase—Phospholamban
—Three-dimensional heart muscle.
In the past 50 years, successful transplantation of
organs has included the kidney, liver, heart, lungs,
pancreas, and small intestines (1). Although organ
transplantation seems like a feasible treatment, there
are many problems associated with this process.
Primarily, the number of patients awaiting an organ
transplant drastically exceeds the amount of organs
available. Another important factor is the postopera-
tive lifestyle of patients after organ transplantation.
These patients have a high risk of developing infec-
tions or possibly an immune response against their
new organ (1).Because organ availability is so limited,
a new field called tissue engineering has evolved and
exploded in the last several decades as a possible
alternative means of treatment for end-stage organ or
tissue failure. The field itself is defined as “devices or
processes that (i) combine living cells and biomateri-
als; (ii) utilize living cells as therapeutic or diagnostic
reagents; (iii) generate tissues or organs in vitro for
subsequent implantation; and/or (iv) provide materi-
als or technology to enable such approaches” (2).
The focus of this study was designed around
cardiac tissue engineering. It is estimated that
approximately 5 million Americans are suffering
from congestive heart failure, and 400 000 patients
are newly diagnosed each year, making this disease
the leading cause of death (3). To be able to engineer
a three-dimensional heart muscle from a patient’s
cells and use it as a patch on the failing myocardium
is the ultimate application goal of cardiac tissue engi-
neering (3). Several approaches to engineer cardiac
tissue in vitro, such as synthetic scaffolds (4), biode-
gradable gels (5–7), and self-organization strategies,
have been evaluated and utilized.
A method previously described, with 100% success
rate, included the utilization of rapidly degrading
fibrin gel to develop functional cardiac muscle in
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vitro using two different approaches: layering and
embedding neonatal cardiac myocytes (8). Up to
800 mN of active force was generated using the layer-
ing approach and validated the cell presence within
the fibrin gel matrix via histological evaluation (8).
Although these models exhibited spontaneous con-
tractile properties, the biologic aspects of the con-
structs have not yet been examined.
An important pathway that controls the rate and
force of relaxation and contractile properties of
cardiac muscle is the calcium-handling pathway
within cardiac myocytes. Briefly, depolarization of the
sarcolemmal membrane in a cardiac muscle cell acti-
vates calcium channels in the cell membrane and sar-
coplasmic reticulum (SR), via ryanodine receptor
(RyR) stimulation, which allows an influx of calcium
from the extracellular space as well as the SR, induc-
ing muscle contraction (9). Next, calcium ions are
quickly recycled back to the SR through a calcium
ATPase of the SR (Sarcoplasmic reticulum Ca++
ATPase [SERCA] 2) channel, resulting in muscle
relaxation (10). In turn, SERCA 2 is regulated by the
phosphorylation state of phospholamban (PBL), an
integral membrane protein that is colocalized with
SERCA 2 (11). It has also been demonstrated to
interact directly with SERCA 2 (12). When PBL is
phosphorylated, it dissociates from SERCA 2 and
allows for the calcium transport into the SR by
SERCA 2 (10) by increase in affinity of calcium to
SERCA 2 (13,14). Dephosphorylation of PBL results
in inhibition of SERCA 2 and a slower reuptake of
calcium back into the SR.
Calcium influx induces muscle contraction through
the myosin–actin interaction. Myosin is abundant in
skeletal and heart muscle and is responsible for
energy transduction and force production (15,16).
Two myosin isoforms are predominant in the cardiac
muscle: myosin heavy chain a (MHC-a) and myosin
heavy chain b (MHC-b). It has been reported that the
speed of contractions in different species are corre-
lated with the variation in the MHC-a/MHC-b ratio
(17) due to electrophoretic activity and ATPase activ-
ity (18). Therefore, it can be concluded that fast-
contracting ventricles of mice and rats contain
predominantly the MHC-a isoform, whereas the
slow-contracting ventricles of humans and bovine
contain predominantly the MHC-b isoform.The ratio
of these two isoforms is variable during postnatal life,
as gene expression fluctuates in response to hor-
mones, changes in cardiac workload, and aging (19).
In the current study, the primary interest was to
analyze the molecular profile of the bioengineered
heart muscle (BEHM) constructs previously
developed. The generation of up to 800 mN of force
was the motive behind observing gene expression of
various calcium-handling markers described above.
Using a neonatal rat heart as a control, the levels of
gene expression between these hearts and BEHM
constructs at various time points during development
were compared. Also, gene expression of cardiac
cells cultured as a two-dimensional monolayer was
observed in order to determine differences of cultur-
ing conditions. As a starting point for the current
study, five genes that are known to have a profound
impact on cardiac muscle physiology were selected:
MHC-a, MHC-b, SERCA2, PLB, and RyR. Knowing
if the BEHM constructs produce a similar level of
calcium-handling protein mRNA as a neonatal heart
will provide a biologic foundation to continue to
develop a stronger and more functional BEHM.
METHODS
National Institute of Health (NIH) guidelines for
the care and use of laboratory animals (NIH Publi-
cation #85-23 Rev. 1985) have been observed. All
materials were purchased from Sigma (St. Louis, MO,
USA) unless otherwise specified.
Isolation of neonatal cardiac myocytes
Cardiac myocytes were isolated from the hearts of
one litter of 2- to 3-day-old F344 rats using an estab-
lished method (20). The hearts were cut into fine
pieces and suspended in a dissociation solution (DS)
that consisted of 0.32 mg/mL collagenase type II
(Worthington Biochemical Corporation, Lakewood,
NJ, USA) and 0.6 mg/mL pancreatin dissolved in a
buffer consisting of 116 mM NaCl, 20 mM HEPES,
1mM Na2HPO4, 5.5 mM glucose, 5.4 mM KCl, and
0.8 mM MgSO4. Digestion was carried out in an
orbital shaker for 5 min at 37°C, after which the
supernatant was replaced with fresh DS and the
digestion process was continued for an additional
90 min.At 45 min, the hearts were further dissociated
using a pipette and then placed back into the orbital
shaker for the other 45 min. At the end of the diges-
tion process, the supernatant was collected, the same
amount of culture medium (CM) was added, consist-
ing of 330 mL M199, 100 mL F12K, 40 mL fetal
bovine serum, 40 mL calf bovine serum, 5 mL
antibiotic-antimycotic, 40 ng/mL hydrocortisone,
30 mg/mL ascorbic acid, 0.5 mM plasma inhibitor,
centrifuged at 1500 rpm for 5 min, and the cell pellet
was resuspended in 10 mL of CM.The cells were then
counted using a hemacytometer. Based on prelimi-
nary experimentation, it was found that increasing
the cell purity by preplating had resulted in a
decrease in active twitch force (manuscript under
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preparation). Also, it was determined that the per-
centage of cardiomyocytes is approximately 40%,
comparable with 70% found in normal mammalian
tissue (R.K. Birla, unpublished results).
Preparation of the plates
The detailed method for preparing the culture
surface for engineering skeletal muscle has been
described in detail (21,22). This procedure was modi-
fied to engineer cardiac muscle (23). Briefly, 35-mm
culture plates were coated with 1.5 mL of a polydim-
ethylsiloxane (PDMS) elastomer (Dow Chemical
Corporation, Midland, MI, USA). Anchor points
were 6-mm-long segments of size 0 braided silk
sutures (Ethicon, Cornelia, GA, USA) pinned 12 mm
apart in the center of the culture surface.
Formation of fibrin gel and cell plating
500 mL CM containing 10 U/mL thrombin was
plated on the surface of 35-mm cell culture plates
coated with SYLGARD (PDMS, type 184 silicone
elastomer, World Precision Inc., Sarasota, FL, USA).
After this, 200 mL of 20 mg/mL fibrinogen was added
to the 35-mm plate. The solution was mixed to
promote the formation of a fibrin gel within
10–15 min in an incubator at 37°C. Primary cardiac
cells were diluted in CM and plated at 1 million cells
in 2 mL of CM/35-mm plate after complete gel
formation. The cells were cultured in an incubator at
37°C and 5% CO2 with medium changes every
second day. Ten 35-mm cell culture dishes were also
plated with 1 million cells in 2 mL of CM without
SYLGARD coating and fibrin gel (Fig. 1).
Experimental design
One heart from a 2- to 3-day-old neonatal rat pup
was frozen in liquid nitrogen immediately post-
removal for RNA isolation. The rest were processed
to isolate primary cardiac myocytes for plating on a
fibrin gel in a 35-mm culture dish. Just prior to
plating, 5 million cells from the cell suspension were
taken out and processed for RNA isolation. The
remainder of the cells were then divided into six
groups, with fix plates per group: 4-day cell mono-
layer, 7-day cell monolayer, 10-day monolayer, 4-day
BEHM, 7-day BEHM, 10-day BEHM. At each des-
ignated day, the cells/BEHMs were analyzed for total
RNA content, cell viability, active force, and specific
force. Extraction of total RNA from the 4-day
BEHM was unsuccessful due to the high gel content
compared with the total cell number embedded.
Thus, the corresponding 4-day cell monolayer was
also not analyzed for mRNA expression. The con-
structs were frozen in liquid nitrogen prior to RNA
isolation and stored at -80°C until processing
(Fig. 2).
Cell viability
To test the cell viability at each point of BEHM
formation, a WST-1 assay protocol (Roche Applied
Science, Indianapolis, IN, USA) was used. Briefly,
100 mL of WST-1 solution was added to culture dishes
containing cells and 2 mL of media. After an over-
night incubation, absorbance was read on a standard
plate reader at 485 nm and compared with a standard
curve. The incubation time was optimized in prior
pilot studies.
FIG. 1. Methods for formation of three-
dimensional BEHM are shown. First, a
layer of PDMS is coated onto a 35-mm cell
culture dish, followed by a fibrin gel. Next,
1 ¥ 106 neonatal cardiac cells are plated
on top of the fibrin gel and allowed to dis-
tribute evenly. Several days postplating,
cardiac myocytes begin to spontaneously
contract, pulling on the fibrin gel. As a
result, the fibrin gel, along with the myo-
cytes, begins to delaminate toward the
middle of the plate and form a three-
dimenstional construct anchored at either
end with anchor points placed previously.
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Evaluation of contraction
The method for evaluating the contractility of
engineered skeletal and cardiac muscle has been
described in detail (23). This method was modified
slightly. Briefly, the BEHM was placed in CM at 37°C
between parallel platinum electrodes. One end was
fixed to the plate and the other end was attached to a
custom-built optical force transducer. Stimulated
active force (response to a single electrical impulse)
measurements were then recorded at 25 V and a
10-ms pulse width. Each BEHM was electrically
stimulated five times, with the average taken. Addi-
tionally, spontaneous contractile force was recorded
for each construct. The cross-sectional area of the
BEHMs was calculated from the construct diameter,
which was determined by a calibrated eyepiece
reticle with a resolution of 5 mm. The construct was
assumed to be cylindrical for this calculation. The
specific force (kN/m2) of each BEHM was deter-
mined by normalizing the stimulated twitch force
to the total cross-sectional area. Initial stimulation
parameters were selected based on previous experi-
ence with engineered cardiac muscle constructs. The
stimulation parameters had been optimized for this
system in pilot experiments.
RNA isolation
All BEHM constructs and neonatal heart were
stored in a -80°C freezer. RNA isolation was per-
formed using the Qiagen RNeasy Mini kit (Qiagen
Inc., Valencia, CA, USA) for BEHM, cell suspension,
and cell monolayers, and the Qiagen RNeasy Midi kit
for neonatal heart. Briefly, the five cell monolayers
from each time point were first trypsinized with 25%
Trypsin-EDTA (Invitrogen Corporation, Auckland,
New Zealand), pooled together, and spun down at
1500 rpm for 5 min into a cell pellet.The 5 million cell
suspension was also spun down at 1500 rpm for 5 min
into a cell pellet. The above cell pellets were then
disrupted with the addition of 350 mL of Buffer
RNeasy Lysis Buffer (RLT). The cells were homog-
enized using a QIAshredder spin column (Qiagen
Inc.); the samples were added to the column and spun
at maximum speed for 2 min. The samples were then
loaded into RNeasy mini columns and subjected to
various washes, according to the manufacturer’s pro-
tocol.The total RNA was eluted with 50 mL of RNase/
DNase-free water. The BEHM constructs followed
the same protocol for RNA isolation, but were
homogenized and disrupted differently. Two BEHM
from each group (<30 g tissue) were homogenized in
600 mL of Buffer RLT using a handheld, cordless
homogenizer (Fisher Scientific Co., Pittsburg, PA,
USA) for 1 min in a 1.5-mL microcentrifuge tube.The
tissue lysate was then centrifuged at maximum speed
for 3 min in a microcentrifuge to pellet cell debris.The
supernatant was then applied to an RNeasy mini
column and subjected to several washes. The total
RNA was eluted with 50 mL of RNase/DNase-free
water. The eluted RNA samples were then pooled
together for the five BEHM constructs in each group.
The neonatal heart, due to its strong collagenous
fibers and weight, was processed by using an RNeasy
Midi Kit. Briefly, the heart was homogenized using
2 mL of Buffer RLT. Next, water and Proteinase K
solution (Qiagen Inc.) was added to the lysate and
incubated at 55°C for 20 min to further break down
the connective tissue, collagen, and the abundance of
contractile proteins.The sample was then centrifuged
at 5000 rpm for 5 min to pellet the cell debris. The
supernatant was then applied to an RNeasy Midi
column and subjected to various washes. The total
RNA was eluted using 350 mL of RNase/DNase-free
water.
After RNA isolation, each sample was analyzed
for nucleic acid purity using the A260/A280 ratio
on a spectrophotometer. Using the 260 nm absor-
bance value, the concentration of nucleic acid within
each sample was determined. The samples were then
stored at -20°C until further processing.
Reverse transcription
cDNA was transcribed following the manufactur-
er’s protocol for the High-Capacity cDNA Reverse
FIG. 2. The experimental design used in
this study is shown. At each time point,
samples were evaluated for the appropri-
ate evaluation, including cell viability, con-
tractile properties, and gene expression.
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Transcription Kit (Applied Biosystems, Foster City,
CA, USA) using 0.8 mg of total RNA, random
primers, and RNase Inhibitor. Each sample contained
20 mL of final volume. Following the manufacturer’s
thermal cycling conditions, the samples were first
incubated at 25°C for 10 min, 37°C for 120 min, 85°C
for 5 s, and finally left at an infinite 4°C hold. Postre-
verse transcription, 80 mL of water was added to each
sample for a 1:5 dilution, and the concentration of
each cDNA sample was taken using the 260 nm
absorbance reading on a spectrophotometer.
Real time reverse transcriptase PCR (RT-PCR)
Real-time, relative quantitative PCR was per-
formed in Biorad’s iCycler detection system using
predeveloped TaqMan Gene Expression Assays
(Applied Biosystems). Briefly, reactions contained
2.9 mL (100 ng) cDNA, 25 mL 2¥ TaqMan Universal
PCR Master Mix (Applied Biosystems), 2.5 mL 20¥
Target Primers and Probe (Gene Expression Assays,
Applied Biosystems), and 19.6 mL of RNase-free
water. The volume per reaction totaled 50 mL. Each
reaction was amplified in triplicate. The target
primers and probes part of the TaqMan Gene
Expression Assays were inventoried, premade
products. The primers of the genes of interest were
chosen to be mRNA specific, spanning an exon–exon
border, minimizing the interference of possible
genomic DNA contamination within the samples.
The relative quantification of each target gene in
each group was normalized to a reference gene
(endogenous control), ribosomal protein 18S. Post-
PCR reaction, the Ct value of each target gene in
each condition was recorded and normalized to the
endogenous control. These data were then used
to determine the fold change in each gene between
the different groups using the manufacturer’s
(BIO-RAD, Hercules, CA, USA) data analysis
method, 2-DDCt.
Histology
Immediately following excision, the neonatal rat
heart was embedded upright in optimal cutting tem-
perature compound (O.C.T.) embedding medium
within a cube-shaped cryomold and dropped in liquid
nitrogen-cooled isopentane. When the BEHM was
fully formed, the sutures at either end were cut with a
blade, and the BEHM was placed in 4% formalin for
24 h. After fixation, the tissues were washed in Dul-
becco’s phosphate buffered saline (DPBS) three
times for 30 min each and stored in a mixture of 30%
sucrose (in DPBS) and O.C.T. embedding medium
overnight to allow the O.C.T. to infiltrate the small
holes within the tissue. The next day, the O.C.T.-
embedded tissues were frozen on dry ice. The tissues
were sectioned in 9 mm sections on SuperFrost Plus
slides (Fisher Scientific Co.) and stored at -80°C until
performing histology. Hematoxylin and eosin (H&E)
staining was used for morphologic analysis of the
constructs and neonatal heart.
Statistical analysis
One-way ANOVAs was used for all pairwise
comparisons. Minitab V13.31 (State College, PA,
USA) was used for statistical analysis.
RESULTS
BEHM formation: WST-1 assay data, force test data
During this study, three-dimensional BEHM con-
structs, using the layering approach, were developed
(described previously). Approximately 50 BEHM
constructs were made during this study, with a 100%
success rate and success being defined as the forma-
tion of contractile constructs. Because the layering
approach was used, the cells were able to evenly dis-
tribute throughout the gel. During formation, all the
constructs developed spontaneous contractions by
the third day after cell seeding, resulting in gel com-
paction and formation of a three-dimensional tissue
construct.
At the day 4 time point, 50% formation of all the
BEHM constructs was observed (Fig. 3A). The diam-
eter average was 6.3  0.13 mm (n = 5). Also, macro-
scopic spontaneous and continuous contractions
throughout each construct could be seen. The con-
structs appeared transparent due to the high amount
of fibrin gel still present. At day 7 time point, all the
BEHM constructs exhibited full formation with a
diameter average of 3.0  0.13 mm (n = 5) (Fig. 3).
The construct also appeared to be less transparent.
All continued to exhibit uniform, macroscopic
contractions. At day 10 time point, the diameter of
the construct continued to decrease, reaching an
average of 1.1  0.12 mm (n = 5) (Fig. 3A). At this
point, the constructs appeared nontransparent and
still displayed the spontaneous contractions observed
at the previous time points.
In order to validate the BEHM model, a WST-1
assay was used to determine the number of viable
cells present.As a preliminary experiment, the appro-
priate amount of time needed to incubate the cells
with the WST-1 reagent was investigated. The results
validated that an overnight incubation allowed the
complete metabolism of the WST-1 reagent by the
cardiac cells (data not shown). The WST-1 assay
results for the BEHM constructs, corresponding to
the 4, 7, and day 10 time points showed no decrease in
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FIG. 3. Various stages of bioengineered
heart muscle formation along with repre-
sentative contractile and histological data
are shown. (A) Spontaneous formation of
BEHM at 4, 7, and 10 days postcardiac cell
plating along with representative graphs of
electrically stimulated active force. Several
days postcell seeding, the cardiac cells
began to contract and pull the fibrin gel
from the plate periphery toward the middle.
With each time point, the diameter of the
BEHM decreased due to the degradation
of the fibrin gel by cardiac cells as they
build their own extracellular matrix. At each
time point, we recorded the values of
active force post-25 V electrical stimu-
lation. The first peak of the graphs shows
the stimulated contraction, while the
second shows a spontaneous contraction.
(B) The active force of contraction and spe-
cific force of BEHM at each time point. For
each group, n = 5 BEHM. (C) The histology
of a fully formed BEHM construct. These
histology sections were H&E stained. The
black arrows point to the nuclei of cardiac
cells, while the white arrow points to the
fibrin gel matrix. * indicates significance
with respect to day 4, for “Active Force,”
P = 0.0266; for “Specific Force, P = 0.0231
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cell numbers, averaging absorbencies of 0.92  0.16
at day 4, 0.87  0.03 at day 7, and 0.92  0.09 at day
10 (n = 5). Based on a linear (R2 = 0.93), cardiac cell
standard curve (data not shown), the absorbancy
values correlated to 1.6, 1.5, and 1.6 million cells at
days 4, 7, and 10, respectively. The absorbancies for
the cell monolayers at each time point also displayed
constant values, providing evidence for nondecreas-
ing cell numbers (data not shown).
Contractile performance of the BEHM constructs
in response to an external, electrical stimulus was also
evaluated in the current study. It was observed that
the peak active force significantly increased between
day 4 and day 7 time points (208  12 mN for day 4
and 361  22 mN for day 7), and then plateaued for
the remaining day 10 time point (344  29 mN, n = 5
for all groups), P = 0.0266. Although the average
peak active force remained constant, the diameter
of the BEHM constructs decreased more than two-
fold and thus produced a higher specific force.
The average specific force, however, significantly
increased for day 7 (0.05  0.003 kPa) and day 10
(0.57  0.08 kPa) time points compared with the day
4 time point (Fig. 3B), P = 0.0231 and P = 0.0161,
respectively.
After complete formation (7–10 days), the BEHM
constructs were fixed and sectioned. An H&E stain
revealed seeded cardiac cells evenly distributed and
surrounded by fibrin gel. Also, a noted difference in
eosin color between the extracellular matrix formed
by cardiac cells (lighter pink) and fibrin gel (darker
red) could be seen. Sporadic patches of undegraded
fibrin gel within cardiac cell clumps were also clearly
visible on the slide. The outside border of the BEHM
construct also looked to have an abundance of
cardiac cells (Fig. 3C).
Based on the contractile, histological, and cell
viability data, the functional performance of the
BEHMs at all time points was confirmed.
Gene expression
RNA was extracted at each time point of the study:
neonatal heart, cell suspension, 4-, 7-, 10-day cell
monolayers, and 7- and 10-day BEHM. RNA extrac-
tion from the 4-day BEHM was unsuccessful using
the RNeasy Midi Kit due to the high volume of fibrin
gel, high weight, and low cell number.All time points,
except the neonatal heart, contained a total number
of 5 million cells. After RNA extraction, quantitative,
real-time RT-PCR was used to characterize the gene
expression of various calcium-handling proteins
between the different conditions and at different
time points within development. The expression of
each gene was normalized to 18S RNA expression,
accounting for any differences in starting amount of
sample during PCR.
The total amount of RNA extracted from each
sample was calculated. As expected, the total RNA
extracted from the neonatal heart (200 mg) drasti-
cally exceeded any other sample. Within each condi-
tion (monolayer culturing vs. BEHM), the total RNA
was highest at the earlier time point (65.1 mg for
4-day monolayer vs. 16.9 mg for 10-day monolayer
and 12.2 mg for 7-day BEHM vs. 9.6 mg for 10-day
BEHM). The monolayer culturing, overall, exhibited
a higher content of total RNA versus the three-
dimensional BEHM culturing.
Figure 4 shows that the expression of all genes
revealed a similar pattern between the conditions
tested. Using the neonatal heart as a control, it was
found that, as expected, this condition contained the
highest gene expression for all five genes. The great-
est difference in gene expression was seen between
the neonatal heart control and both of the time
points within the cell monolayer conditions, where
gene expression had a fold change of less than 0.1.
The Ct values for MHC-b and RyR were so high
within the 7-day monolayer that the expression of
these genes was taken to be zero, when compared
with the neonatal heart.
The BEHM condition exhibited gene expression
with a much lower difference when compared with
the neonatal heart, versus comparing the monolayers
to the neonatal heart.The MHC-b expression had the
lowest difference overall, with a fold change of 0.9 for
day 7 time point and a fold change of 0.5 for day 10
time point. Day 7 time point for BEHM constructs
exhibited a higher gene expression for all genes than
day 10 time point, respectively, with fold differences
of 0.2 and 0.1 for MHC-a, 0.4 and 0.1 for SERCA 2
and 0.5 and 0.3 for both PBL and RyR.
A direct comparison of gene expression between
the 7-day BEHM and monolayer, and the 10-day
BEHM and monolayer was also evaluated (Fig. 5). It
was determined that the expression for almost all
genes is higher within the BEHM construct. MHC-a
exhibited an almost 2600-fold increase in its expres-
sion between day 7 time points of monolayer to
BEHM and a 100-fold increase between the 10-day
time points. The MHC-b and RyR gene expression at
day 7 between the two culturing conditions was
incomparable because there was an undetectable
amount of the gene present in the 7-day BEHM
construct. There was, however, a 70-fold increase in
MHC-b and a 74-fold increase in RyR going from the
10-day monolayer to 10-day BEHM. The rest of
the genes displayed a similar pattern of increase
in expression from the monolayer to the BEHM
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construct within each day, with a 19-fold and sixfold
increase of SERCA 2 at 7 days and 10 days, respec-
tively, and a 158-fold and 24-fold increase of PBL at 7
days and 10 days, respectively.
Gene expressions between the neonatal heart and
cell suspension approximately 2 h after the beginning
of the cell isolation process was observed. It was
found that the cells in the suspension showed gene
expression for all calcium handling genes. The most
expressed genes were SERCA 2 and PBL, with a fold
change of 0.5 compared with that of the neonatal
heart. The next highest was MHC-b with a fold
change of 0.4, and finally MHC-a and RyR with a




FIG. 4. Gene expression of calcium-handling genes of various conditions relative to neonatal rat heart. (A) MHC-a, (B) MHC-b, (C)
SERCA 2, (D) Phospholamban, (E) RyR. The total cell number for each condition, excluding the neonatal heart, was 5 ¥ 106 cells.
Real-time RT-PCR results were normalized to 18S rRNA expression at each condition and time point and then reported relative to the
neonatal rat heart control sample. * indicates significance with respect to neonatal heart group, P = 8.26 ¥ 10-24 (MHC-a), P = 4.1 ¥ 10-19
(MHC-b), P = 4.0 ¥ 10-16 (SERCA 2), P = 2.0 ¥ 10-15 (phospholamban), and P = 2.0 ¥ 10-26 (RyR). Error bars represent SD.
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The change in gene expression between the two
time points during BEHM formation, at 7 and 10
days, was also analyzed. Day 7 time point was used as
the comparative control. It was determined that
expression of all genes was highest at day 7 time
point. MHC-b exhibited the lowest difference in
expression than all other markers, 0.6 of the 7-day
BEHM construct. Approximately 0.5-fold of gene
expression was seen in phospholamban and RyR, 0.4
for MHC-a, and 0.3 for SERCA 2 (Fig. 6).
An important observation that was extrapolated
from the results is the ratio of MHC-b to MHC-a and
SERCA 2 to phospholamban. The approximate
control ratio of the neonatal heart for MHC-b to
MHC-a was 1.7. The condition that came closest to
the control was the cell suspension, with a ratio of 1.5.
The ratio was 1.4 for the 10-day monolayer, 1.3 for
the 7-day BEHM, and 1.1 for the 10-day BEHM.
Calculating the MHC-b/MHC-a ratio for the 7-day




FIG. 5. Gene expression of calcium-handling genes of BEHM at days 7 and 10 time points relative to cell monolayer culturing at days
7 and 10 time points. (A) MHC-a, * P = 1.59 ¥ 10-15, # P = 1.47 ¥ 10-15. (B) MHC-b, # P = 2.73 ¥ 10-17. (C) SERCA 2, * P = 1.28 ¥ 10-15,
# P = 8.47 ¥ 10-13. (D) Phospholamban, * P = 5.5 ¥ 10-18, # P = 7.55 ¥ 10-11. (E) RyR # P = 1.4 ¥ 10-14. * indicates significance with respect
to day 7 time point, and # indicates significance with respect to day 10 time point. Error bars represent SD.
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of MHC-b was undetectable in that condition
(Fig. 7A).
The SERCA 2/PBL ratio measures the reuptake of
calcium ions back into the SR after depolarization.
The two markers are colocalized and work together,
and it is evident in the neonatal heart ratio of 0.95.
This ratio did not fluctuate greatly between BEHM
conditions, 0.96 and 1.03 at days 7 and 10 time points,
respectively (Fig. 7B).
DISCUSSION
The previously developed three-dimensional heart
muscle in vitro by Huang et al. demonstrated spon-
FIG. 6. Expression of calcium-handling
genes during the course of formation
of BEHM at 10 days relative to 7 days.
* indicates significance with respect to day
7 time point, P = 2.79 ¥ 10-21 (MHC-a),
P = 2.94 ¥ 10-15 (MHC-b), P = 6.8 ¥ 10-18
(SERCA 2), P = 1.2 ¥ 10-9 (phospholam-
ban), P = 4.98 ¥ 10-17 (RyR). Error bars
represent SD.
FIG. 7. Gene expression ratios of MHC-b
to MHC-a (A) and SERCA 2 to phospho-
lamban (B) in the 3- to 4-day neonatal rat
heart, the 7-day and 10-day BEHM. * indi-
cates significance with respect to neonatal
heart group. (A) P = 2.71 ¥ 10-20 (7-day
BEHM), P = 6.47 ¥ 10-21 (10-day BEHM).
(B) P = 0.0332 (7-day BEHM), P = 3.
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taneous and electrically stimulated contractions. In
previous studies, a promising in vitro model of heart
muscle or BEHM was engineered, and, in the current
study, the main objective was to compare how the
BEHM constructs compared biologically with native
myocardial tissue. This was achieved by examining
the intracellular biologic functioning of the calcium
handling pathway, by comparing the gene expression
of various critical biologic markers between a whole
neonatal rat heart, cell suspension, monolayer
culture, and BEHM.
The first objective of the current study was to
reproduce the method for the formation of BEHMs.
The model is fairly new and thus requires some expe-
rience to recreate. Successful recreation of a fully
formed and viable BEHM construct was accom-
plished, and all stages of the process were completely
reproducible. The formation of viable tissue con-
structs was supported by microscopic evaluation,
WST-1 data, as well as histological and contractile
performance metrics. Due to the nonchanging absor-
bance values, the WST-1 assay showed that the cells
were thriving and not decreasing in number through-
out all time points in the cell monolayers and BEHM
constructs.
Histological evaluation showed numerous clumps
of cells surrounded by a lighter-pink fibrin gel.As the
cells began to develop their own extracellular matrix,
they concomitantly degraded the fibrin gel. This was
evident through an H&E stain of a fully formed
BEHM construct. The abundance of cells and their
own extracellular matrix (darker pink/purple) greatly
exceeded the presence of the fibrin gel (brighter
pink). Because the cells were initially distributed
evenly on the fibrin gel, they were able to build their
own network of extracellular proteins and begin to
contract in spontaneous rhythm, compacting into a
three-dimensional construct from a cell monolayer.
Another test of viability and reproducibility that
was performed at each time point of BEHM forma-
tion was the measure of force generated after elec-
trical stimulation. As can be seen in Fig. 3B, the
active force significantly increased between day 4
(208  12 mN) and day 7 (361  22 mN), and then
leveled off by day 10 (343.6  29 mN). This, however,
was not a true measurement of the maximal force
that was generated because these numbers are
dependent on the diameter of each construct. Even
though the peak active force stayed constant between
days 7 and 10, the diameter decrease between these
time points indicated a drastic increase in specific
force. The specific force significantly increased from
0.007  0.002 kPa for day 4 time point to 0.05 
0.01 kPa for day 7 time point and significantly
increased to 0.57  0.42 kPa for day 10 time point.
These results showed a general increase in force
production and further illustrated that the BEHM
constructs contained viable cells integrated within a
network. Collectively, the data validated the forma-
tion of functional three-dimensional BEHMs at
various time points.
The next objective of this study was to determine
the differences in gene expression of various calcium-
handling proteins between culturing methods of neo-
natal cardiac cells. Because cardiac tissue engineering
is a relatively new field of research and also focuses
most of its efforts on developing mechanically sound
models, little research investigating the biology of the
bioengineered tissues has been published. First, the
effect of cell isolation from a neonatal rat heart on
gene expression was determined. It can be seen from
Fig. 4 that all five genes investigated in this study
exhibited a decrease in gene expression between a
neonatal heart and a cell suspension. This may have
been due to the fact that, in a cell suspension, 2 h into
the cell isolation process, the extracellular matrix was
being degraded and the cardiomyocytes had lost
most of their connections to each other and thus
decreased their production of calcium-handling pro-
teins needed to maintain the rigorous and steady
contractions. Even though the expression of the
calcium-handling genes slightly declined between the
neonatal heart and cell suspension, this result gave
valuable validation for the isolation methods. The
cardiac cells within this suspension were not embed-
ded within an extracellular network and were not
adhered to each other; yet they still exhibited
transcription. Through these results, it was concluded
that, throughout the cell isolation process, most of the
cardiac cells are viable.
Next, the effects of culturing environments on
cardiac cells were compared. It was important to vali-
date the three-dimensional model against the two-
dimensional cell monolayer. The BEHM constructs
exhibited the ability to produce active force post-
electrical stimulation as well as beat spontaneously.
Due to this, a fairly high expression of calcium-
handling genes was expected. The difference in gene
expression between the neonatal heart and BEHM
constructs at both days 7 and 10 time points was
lower than that of the neonatal heart and 7- and
10-day cell monolayers. This is also seen in Fig. 5,
where the days 7 and 10 monolayer time points were
used as controls, while comparing gene expression to
that of the 7- and 10-day BEHM constructs. It is
possible that the fibrin gel provided a suitable extra-
cellular network for the cardiac cells to redevelop
their role as force producers after being disrupted
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from their previous environment. Having the initial
support of a fibrin gel, the cells were able to start
producing their own extracellular matrix while
degrading the fibrin gel and started reorganizing
themselves into a three-dimensional tissue that
contracted spontaneously and responded to electric
stimulation as an entire unit instead of individual
cells with each passing time point. Within the mono-
layer, the only connections that the cardiac cells had
were with several neighboring cells and a culture dish
that promotes adhesiveness of cells. In this culturing
environment, cardiac cells may not have been able to
form an appropriate matrix to be able to timely relay
spontaneous contraction in order to beat as a whole
tissue. Also, these cardiac cells were unable to spon-
taneously form into a three-dimensional model due
to the attractive forces of the culture dish surface. It
was concluded from these results that seeding freshly
isolated cardiac cells onto a biodegradable gel, such
as a fibrin gel, produced a better culturing environ-
ment for the cells to spontaneously reorganize them-
selves into a whole tissue and be able to exhibit the
contractile properties of a normal myocardium. Gen-
erally, cultured cells, whether in a three-dimensional
model or a two-dimensional monolayer, begin to
produce their own extracellular matrix, contributing
to the ability for contraction.The advantage of three-
dimensional culturing is that it gives these cells the
ability to reorganize themselves further rather than
be confined to one spot as a monolayer. This re-
organization gives the construct, as a whole, a more
organized morphology, similar to that of native
myocardial tissue.
The 7-day BEHM construct and the 10-day BEHM
construct were compared next, in order to determine
the effects of time in culture on gene expression of
calcium-handling proteins. It was found that, using
day 7 time point as the relative control, that expres-
sion for all five genes exhibited a higher level at 7
days. The energy and nutrient requirements for the
metabolism of cardiac cells are extremely high. An
ideal culturing condition for these constructs would
be a perfusion system that constantly replenishes the
media with nutrients to allow the cardiac cells to
function at their maximal capacity. Also, bioreactors
would continuously stimulate contractions within
the BEHM in order to allow the cells to adapt to
the constant physical and/or electrical stimulation to
make them stronger and develop into more efficient
muscle tissues.
The ability for BEHM constructs to spontaneously
contract led to the investigation of the role of MHC-
b/MHC-a expression ratio. It has been documented
that, within most of the cardiac development of a rat
fetus, the MHC-b isoform is strictly limited to the
ventricular chamber cells, while the MHC-a isoform
is highly expressed in the atrial cells (19,24). Later in
fetal development and close to birth, MHC-a tran-
scription begins to take place within the ventricular
cardiomyocytes and by day 7 post birth and almost all
of the MHC-b isoform is replaced by MHC-a isoform
(24). During human development, however, MHC-b
is the predominant isoform expressed in ventricular
myocytes in both the fetal and adult life, while the
MHC-a isoform is expressed in the atrium (25,26).
In the results of the current study, it was found that
the ratio of MHC-b to MHC-a was at 1.7 for the
neonatal heart. It is believed that this ratio is so high
because the heart (at days 3 to 4 postbirth) has not
yet had enough time to fully replace all the MHC-b
with the MHC-a isoform. Both of these isoforms
were present at this time because the process was
well underway toward postnatal development. There
was a slight decrease in this ratio during the 7- and
10-day BEHM development. If the neonatal heart
had not been disrupted, the most likely scenario
would have been the complete replacement of
MHC-b with MHC-a. However, because the cells
were isolated and subsequently cultured in vitro, they
were not able to take on their end-stage role as fast-
twitch, MHC-a cardiomyocytes. It would be interest-
ing to observe the ratio of MHC-b to MHC-a in
BEHM constructs cultured for longer than 10 days. In
that case, a comparison of the ratio to a native adult
myocardium would be useful to see if the construct
develops an adult phenotype of contractile proteins.
As mentioned in the introduction, SERCA 2 and
PBL are colocalized with each other. Also, the phos-
phorylation of PBL leads to the enhancement of
SERCA 2 by increasing its affinity to calcium ions. It
has been reported that, for an adult rodent heart, the
SERCA 2/PBL ratio in the ventricle varies between
1.0 and 1.9 (27,28). The SERCA 2/PBL ratio of the
neonatal heart was 0.95. This ratio did not fluctuate
much between the other conditions. These results
provided evidence that the genes responsible for
calcium reuptake were consistently and concomi-
tantly expressed.
CONCLUSIONS
A successful comparison of gene expressions of
five calcium-handling proteins between a neonatal
heart and various culturing conditions was achieved.
It was concluded that culturing the cells in a three-
dimensional environment produces tissues that more
closely resemble native cardiac tissue (29–31). There
still needs to be a lot more research done in order to
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develop the perfect culturing conditions which will
provide the correct and adequate amount of nutri-
ents to each cell. For now, the current model
described is a good building block for development
of tissues that will one day be used on patients with
end-stage heart failure.
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